HighTower Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.19M | Sell |
25,004
-2,505
| -9% | -$132K | ﹤0.01% | 2070 |
|
|
2025
Q4 | $1.44M | Buy |
27,509
+783
| +3% | +$46.9K | ﹤0.01% | 1869 |
|
|
2025
Q3 | $1.73M | Sell |
26,726
-22,470
| -46% | -$1.29M | ﹤0.01% | 1718 |
|
|
2025
Q2 | $2.39M | Buy |
49,196
+16,163
| +49% | +$625K | ﹤0.01% | 1471 |
|
|
2025
Q1 | $1.12M | Buy |
33,033
+1,325
| +4% | +$56.2K | ﹤0.01% | 1885 |
|
|
2024
Q4 | $1.25M | Sell |
31,708
-6,608
| -17% | -$312K | ﹤0.01% | 1817 |
|
|
2024
Q3 | $1.79M | Sell |
38,316
-1,349
| -3% | -$68.4K | ﹤0.01% | 1581 |
|
|
2024
Q2 | $2.15M | Sell |
39,665
-2,908
| -7% | -$168K | ﹤0.01% | 1411 |
|
|
2024
Q1 | $2.9M | Buy |
42,573
+5,043
| +13% | +$361K | ﹤0.01% | 1236 |
|
|
2023
Q4 | $2.36M | Sell |
37,530
-2,465
| -6% | -$136K | ﹤0.01% | 1351 |
|
|
2023
Q3 | $1.81M | Sell |
39,995
-36
| -0.1% | -$1.86K | ﹤0.01% | 1433 |
|
|
2023
Q2 | $2.25M | Sell |
40,031
-228
| -0.6% | -$12.9K | ﹤0.01% | 1287 |
|
|
2023
Q1 | $1.82M | Buy |
40,259
+9,747
| +32% | +$473K | ﹤0.01% | 1342 |
|
|
2022
Q4 | $1.23M | Sell |
30,512
-4,898
| -14% | -$260K | ﹤0.01% | 1556 |
|
|
2022
Q3 | $2.32M | Buy |
35,410
+1,421
| +4% | +$103K | 0.01% | 1154 |
|
|
2022
Q2 | $2.06M | Sell |
33,989
-15,894
| -32% | -$934K | 0.01% | 1245 |
|
|
2022
Q1 | $3.13M | Buy |
49,883
+16,494
| +49% | +$1.04M | 0.01% | 1121 |
|
|
2021
Q4 | $2.54M | Sell |
33,389
-9,770
| -23% | -$854K | 0.01% | 1228 |
|
|
2021
Q3 | $4.83M | Buy |
43,159
+3,006
| +7% | +$378K | 0.01% | 833 |
|
|
2021
Q2 | $6.49M | Buy |
40,153
+10,668
| +36% | +$1.3M | 0.02% | 702 |
|
|
2021
Q1 | $3.58M | Buy |
29,485
+3,014
| +11% | +$455K | 0.01% | 859 |
|
|
2020
Q4 | $4.05M | Buy |
26,471
+1,497
| +6% | +$177K | 0.02% | 653 |
|
|
2020
Q3 | $2.09M | Sell |
24,974
-385
| -2% | -$34.2K | 0.01% | 858 |
|
|
2020
Q2 | $1.86M | Buy |
25,359
+4,809
| +23% | +$281K | 0.01% | 833 |
|
|
2020
Q1 | $873K | Buy |
20,550
+1,850
| +10% | +$95.5K | 0.01% | 1076 |
|
|
2019
Q4 | $1.13M | Buy |
18,700
+1,075
| +6% | +$58.7K | 0.01% | 1084 |
|
|
2019
Q3 | $722K | Sell |
17,625
-5,043
| -22% | -$241K | ﹤0.01% | 1341 |
|
|
2019
Q2 | $1.07M | Buy |
22,668
+2,523
| +13% | +$101K | 0.01% | 1161 |
|
|
2019
Q1 | $721K | Buy |
20,145
+3,453
| +21% | +$119K | ﹤0.01% | 1279 |
|
|
2018
Q4 | $480K | Sell |
16,692
-7,669
| -31% | -$267K | ﹤0.01% | 1373 |
|
|
2018
Q3 | $1.08M | Buy |
24,361
+4,920
| +25% | +$258K | 0.01% | 1092 |
|
|
2018
Q2 | $1.14M | Buy |
+19,441
| New | +$1.11M | 0.01% | 1060 |
|
Other funds holding CRSP
AIM
OAG
GP
SOCM
